This category compiles background information and best practices for antibody work. Topics include selection criteria, handling protocols, and other practical tips for research and clinical settings.
Antibodies defend health by neutralizing pathogens, aiding phagocytosis, and activating complement. Biointron explains these vital functions in immunity and therapy.
Analytical tools define antibody quality. Biointron applies SPR, BLI, and mass spectrometry to deliver precise characterization and support therapeutic success.
Antibody-drug conjugates unite precision with potency. Biointron outlines how ADCs combine antibodies with cytotoxic drugs to deliver targeted cancer therapies.
Fab, F(ab’)2, and Fc fragments expand antibody applications. Biointron explains their structures and how they advance diagnostics, imaging, and therapeutic innovation.
Agonist antibodies activate receptors to modulate biology. Biointron explores their mechanisms, therapeutic promise, and applications in immune regulation and oncology.
Antibodies defend against disease and power modern biotech. Biointron shares ten fascinating facts that highlight their versatility and impact in research and therapy.
Antibodies regulate immune responses and support biological balance. Biointron explains these key roles and their importance in therapeutic innovation and research.
Single-chain variable fragments (scFvs) combine small size with strong binding. Biointron highlights their history, uses in diagnostics and therapy, and production expertise.
Antibodies neutralize pathogens, opsonize invaders, and activate complement. Biointron highlights these essential functions as the foundation for antibody drug development.
VHH antibodies offer stability, small size, and unique binding advantages. Biointron highlights their history, applications, and growing role in research and therapeutics.
Autoantibodies can defend the body or drive disease. Biointron explores their dual roles in health and autoimmunity, from protective functions to impacts in lupus and COVID-19.
Personalized antibody therapies bring precision to treatment. Biointron highlights how monoclonal antibodies and ADCs target cancer, IBD, and other diseases with improved outcomes.
You can also contact us on the Scientist and Science Exchange marketplaces.
